| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.099 | 0.5 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.03 | 0.5 |